Cardinal Health, Inc. (CAH) Return on Equity (ROE): -56.13%
Is Cardinal Health, Inc.’s return on equity (ROE) high or low?
Cardinal Health, Inc.'s return on equity (ROE) of -56.13% is 152% below its 5-year average of -22.30%, around the middle of its 5-year range (-206.43%–132.30%).
As of Monday, June 15, 2026. 35.83% below its 12-month average of -41.33%.
CAH Return on Equity (ROE) Chart
CAH Average Return on Equity (ROE) Chart
CAH Current vs Average Return on Equity (ROE) Chart
CAH Return on Equity (ROE) Metrics
RETURN ON EQUITY (ROE)
-56.13%
RETURN ON EQUITY (ROE) AVG TTM
-41.33%
RETURN ON EQUITY (ROE) AVG 3Y
9.62%
RETURN ON EQUITY (ROE) AVG 5Y
-22.30%
RETURN ON EQUITY (ROE) AVG 10Y
-4.36%
RETURN ON EQUITY (ROE) AVG 15Y
11.68%
RETURN ON EQUITY (ROE) AVG 20Y
15.21%
CURRENT VS TTM AVG
-35.83%
CURRENT VS 3Y AVG
-683.32%
CURRENT VS 5Y AVG
-151.67%
CURRENT VS 10Y AVG
-1187.92%
CURRENT VS 15Y AVG
-580.63%
CURRENT VS 20Y AVG
-469.10%
CAH Competitors' Return on Equity (ROE)
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardinal Health, Inc. (CAH) | $52.43B | -56.13% | -41.33% | 9.62% | -22.30% |
| Becton, Dickinson and Company (BDX)vs › | $52.98B | 4.72% | 6.60% | 6.50% | 6.42% |
| Cencora, Inc. (COR)vs › | $54.80B | 75.01% | 168.34% | -32.99% | 148.52% |
| Humana Inc. (HUM)vs › | $45.53B | 6.08% | 7.05% | 11.93% | 15.09% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.24B | 70.38% | 60.82% | 72.53% | 81.69% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $63.06B | 14.08% | 14.72% | 15.95% | 23.11% |
| Agilent Technologies, Inc. (A)vs › | $36.67B | 19.85% | 20.59% | 21.51% | 20.54% |
| Zoetis Inc. (ZTS)vs › | $33.36B | 81.75% | 66.19% | 56.82% | 52.60% |
| Centene Corporation (CNC)vs › | $32.19B | -30.07% | -10.46% | -1.37% | 1.10% |
| Medline Inc. (MDLN)vs › | $30.96B | 8.55% | 9.02% | 4.86% | 4.86% |
Return Analysis
ROE
-56.1%
ROA
2.8%
Cardinal Health, Inc. Return on Equity (ROE) Formula & Definition
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cardinal Health, Inc. Return on Equity (ROE) FAQ
- What is the return on equity (ROE) for Cardinal Health, Inc. (CAH)?
- The return on equity (ROE) for CAH stock is -56.13%.
- Is Cardinal Health, Inc.'s return on equity (ROE) high or low?
- Cardinal Health, Inc.'s return on equity (ROE) of -56.13% is 152% below its 5-year average of -22.30%, around the middle of its 5-year range (-206.43%–132.30%).
- What is the TTM average return on equity (ROE) for Cardinal Health, Inc. (CAH)?
- The TTM average return on equity (ROE) for CAH stock is -41.33%.
- What is the 3Y average return on equity (ROE) for Cardinal Health, Inc. (CAH)?
- The 3Y average return on equity (ROE) for CAH stock is 9.62%.
- What is the 5Y average return on equity (ROE) for Cardinal Health, Inc. (CAH)?
- The 5Y average return on equity (ROE) for CAH stock is -22.30%.
- What is the 10Y average return on equity (ROE) for Cardinal Health, Inc. (CAH)?
- The 10Y average return on equity (ROE) for CAH stock is -4.36%.
- What is the 15Y average return on equity (ROE) for Cardinal Health, Inc. (CAH)?
- The 15Y average return on equity (ROE) for CAH stock is 11.68%.
- What is the 20Y average return on equity (ROE) for Cardinal Health, Inc. (CAH)?
- The 20Y average return on equity (ROE) for CAH stock is 15.21%.
Cardinal Health, Inc. Return on Equity (ROE) History
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-06-30 | -56.13% |
| 2024-06-30 | -26.52% |
| 2023-06-30 | -11.16% |
| 2022-06-30 | 132.30% |
| 2021-06-30 | 34.12% |
| 2020-06-30 | -206.43% |
| 2019-06-30 | 21.54% |
| 2018-06-30 | 4.23% |
| 2017-06-30 | 18.92% |
| 2016-06-30 | 21.77% |
| 2015-06-30 | 19.42% |
| 2014-06-30 | 18.22% |
| 2013-06-30 | 5.59% |
| 2012-06-30 | 17.12% |
| 2011-06-30 | 16.40% |
| 2010-06-30 | 12.17% |
| 2009-06-30 | 13.20% |
| 2008-06-30 | 16.79% |
| 2007-06-30 | 26.18% |
| 2006-06-30 | 11.78% |
| 2005-06-30 | 12.23% |
| 2004-06-30 | 18.49% |
| 2003-06-30 | 18.32% |
| 2002-06-30 | 16.52% |
| 2001-06-30 | 15.77% |
| 2000-06-30 | 15.45% |
| 1999-06-30 | 12.78% |
| 1998-06-30 | 8.36% |
| 1997-06-30 | 13.57% |
| 1996-06-30 | 10.80% |
Related Metrics
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Jason Hollar